Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy

Clinical trial NCT04571216 · COMPLETED

Trial details

NCT number: NCT04571216
Sponsor: NFL Biosciences SAS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Smoking Cessation Nicotine Dependence

Start date: 2021-04-12
Primary completion: 2024-04-12
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.